Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |